The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A review of clinical endpoints and use of quality of life outcomes in phase III metastatic breast cancer clinical trials.
Raman Tatla
No relevant relationships to disclose
Denis Landaverde
No relevant relationships to disclose
Charles Victor
No relevant relationships to disclose
David Miles
No relevant relationships to disclose
Sunil Verma
No relevant relationships to disclose